These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6683555)

  • 1. [Effect of sulmazol on left ventricular function in congestive cardiomyopathy].
    Maurer E; Klein W; Brandt D
    Arzneimittelforschung; 1983; 33(5):760-3. PubMed ID: 6683555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the acute effect of AR-L 115 BS, a new positive-inotropic agent in patients with exercise-induced heart failure.
    Drexler H; Wollschläger H; Löllgen H; Just H
    Arzneimittelforschung; 1981; 31(1a):259-62. PubMed ID: 7195237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hemodynamic effect of AR-L 115 BS, a new positive-inotropic agent, in patients with left ventricular failure.
    Wollschläger H; Drexler H; Löllgen H; Just H
    Arzneimittelforschung; 1981; 31(1a):248-50. PubMed ID: 7195233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute effect of a new positive inotropic agent (AR-L 115 BS) on cardiac hemodynamics and contractility in patients with severe chronic congestive heart failure.
    Hauf GF; Bubenheimer P; Roskamm H
    Arzneimittelforschung; 1981; 31(1a):253-6. PubMed ID: 7195235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of single-dose administration of AR-L 115 BS in patients with coronary artery disease.
    Weikl A; Kohlschütter S; Durst OE; Lang E
    Arzneimittelforschung; 1981; 31(1a):244-7. PubMed ID: 7195232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sulmazole: a new positive inotropic agent].
    Renard M; Jacobs P; Melot C; Dresse A; Bernard R
    Ann Cardiol Angeiol (Paris); 1984; 33(4):219-22. PubMed ID: 6465815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute hemodynamic effects of alifedrine in patients with heart failure].
    Schanzenbächer P; Riegger G; Liebau G; Hockerts T; Kochsiek K
    Z Kardiol; 1984 Feb; 73(2):95-100. PubMed ID: 6719988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute clinical benefits of a new inotropic agent AR-L 115 BS after i.v. and oral administration.
    el Allaf D; D'Orio V; Cremers S; Carlier J
    G Ital Cardiol; 1984 Oct; 14(10):830-4. PubMed ID: 6519393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new non-glycoside, non-adrenergic cardiotonic agent AR-L 115 BS. Hemodynamic proof of its efficacy after both i.v. and oral administration.
    Thormann J; Kramer W; Schlepper M
    Arzneimittelforschung; 1981; 31(1a):273-8. PubMed ID: 7195241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new orally active positive inotropic substance: AR-L 115 BS.
    Ruffmann KD; Mehmel HC; Kübler W
    Arzneimittelforschung; 1981; 31(1a):271-3. PubMed ID: 7195240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of AR-L 115 BS on myocardial oxygen consumption, cardiac performance and vascular resistance and capacitance.
    Dämmgen J; Kadatz R; Diederen W
    Arzneimittelforschung; 1981; 31(1a):151-4. PubMed ID: 7195209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemodynamics and clinical data in chronic coronary disease with severe left ventricular systolic dysfunction].
    Marinato PG; Dametto E; Maragno I; Razzolini R; Chinellato P; Santostasi G; Dalla Volta S
    Cardiologia; 1996 Apr; 41(4):349-59. PubMed ID: 8674104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic activity of different doses of sulmazole by infusion.
    Mendiola-García A; Fernández-Fernández JL; Tello-Arias A; Camacho-Rivera B
    Arzneimittelforschung; 1983; 33(11):1594-8. PubMed ID: 6686455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First clinical trial with etomoxir in patients with chronic congestive heart failure.
    Schmidt-Schweda S; Holubarsch C
    Clin Sci (Lond); 2000 Jul; 99(1):27-35. PubMed ID: 10887055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of AR-L 115 BS on hemodynamics and contractility of the heart in cardiac patients.
    Stauch M; Nechwatal W
    Arzneimittelforschung; 1981; 31(1a):267-71. PubMed ID: 7195239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
    Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodynamic effects of a new positive inotropic agent (AR-L 115 BS) in ischemic and nonischemic myocardiopathies].
    Colle JP; Ohayon J; Ledain L; Besse P
    Arch Mal Coeur Vaiss; 1984 Dec; 77(13):1532-9. PubMed ID: 6440503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset and magnitude of cardiovascular response to dobutamine and AR-L 115 BS, a new positive inotropic agent with additional vasodilating activity, in normal subjects.
    Benedikter L; Mey T
    Arzneimittelforschung; 1981; 31(1a):239-42. PubMed ID: 7195230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.